Although NPM1 was not an independent prognostic factor based on our COX-regression analysis (Supplementary Table 3), our analysis showed that patients with negative hormone receptor expression tended to have higher level of NPM1 (Supplementary Table 4), suggesting that NPM1 still had prognostic value in breast cancer treatment. The gene discussed is NR4A1; the disease is breast carcinoma.